MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Madrigal Pharmaceuticals, Inc. Common Stock

MDGL

#778
Madrigal Pharmaceuticals, Inc. Common Stock
432.0000
-0.54%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
432.0000
432.0000
Intervallo Annuale
393.6050
614.3600
Variazione giornaliera
-0.54%
Variazione Mensile
-14.35%
Variazione di 6 mesi
+1.98%
Variazione Annuale
+1.98%
Chiusura Precedente
434.3600
Open
432.0000
Bid
Ask
Low
432.0000
High
432.0000
Volume
139
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. MDGL
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

Notizie

Seeking Alpha Seeking Alpha
MDGL
2026.02.25
Madrigal: The Easiest Money May Have Been Made (NASDAQ:MDGL)
Seeking Alpha Seeking Alpha
NVO LLY HIMS MDGL TEVA
2026.02.23
Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)
Investing Investing
MDGL
2026.02.23
H.C. Wainwright conferma il rating Buy su Madrigal Pharmaceuticals
Investing Investing
MDGL
2026.02.23
H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy
Zacks Zacks
MDGL CSTL HRMY IMCR
2026.02.20
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Investing Investing
BAC-PS DE GS-PA LRCX MA
2026.02.19
Lam Research, Goldman Sachs among market cap stock movers on Thursday
Seeking Alpha Seeking Alpha
MDGL
2026.02.19
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript
Investing Investing
DE ORCL LRCX OXY-WT CF
2026.02.19
Oracle, Deere among market cap stock movers on Thursday
Investing Investing
MDGL
2026.02.19
Madrigal Q4 2025 slides: Rezdiffra nears $1B in first year sales despite EPS miss
Zacks Zacks
MDGL COLL
2026.02.19
Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates
Investing Investing
MDGL
2026.02.19
Le azioni Madrigal Pharma calano oltre il 5% per utili Q4 deludenti
Investing Investing
MDGL
2026.02.19
Madrigal Pharma shares fall over 5% as Q4 earnings miss overshadows revenue beat

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd